Medical Manager HemophiliaRoche Pharma AG, Grenzach-Wyhlen, GermanyGrenzach-Wyhlen, Baden-Wurttemberg, Germany
PB0262 - Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: Third interim analysis of the non-interventional study EMIIL
Sunday, June 23, 202413:45 – 14:45 ICT
